.png)
Why Short-Term Cardiomyocytes Undermine Long-Term Cardiac Programs
Beyond binding – iPSC-based functional safety screening for oncology modalities
Advancing Gene Therapy Potency Testing with iPSC-Based Systems
Revolutionizing Cardiac Safety Assessment with NHP Cardiomyocytes
A Reduction in Animal Testing Stems From Ncardia
See How Ncardia Is Supporting the Shift From Animal Models With iPSC Technology
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
